Addiction Clinical Trial
Official title:
Opioid Physiology Project
The current project seeks to explore the use of emergent biosensor technology to detect opioid use. The investigators goal is to recruit 60 opioid naïve patients presenting at the College of Dentistry at UTHSC. Candidate participants must be scheduled for an upcoming dental procedure that will involve subsequent pain management using oral opioid medication. Participants will be consented prior to any study procedures. All participant information from this study will be kept strictly confidential (e.g., no individual data will be shared with the College of Dentistry).
Opioid overdose is a leading cause of accidental death in the USA, with death rates rising
steadily over the last 20 years (CDC, 2015). Of the over 22,000 deaths relating to
pharmaceutical overdose in 2011, three quarters involved opioid analgesics (Fletcher et al.,
2011). Increases in problematic opioid use have paralleled a corresponding increase in drug
treatment admissions (DOHH, 2014). Drug treatment programs currently focus on behavioral and
pharmacologic interventions to sustain abstinence, and success is typically measured by
self-reports or urine drug screening (NIDA, 2016). Both measurement methods are limited by
such factors as recall bias, distortion, and lack of precision (Fishman et al., 2000). A
detection method that accurately detects opioid use as it occurs in real time would provide
several distinct advantages, including the ability to obtain environmental and behavioral
contexts surrounding relapse as well as an opportunity for targeted interventions.
The current project seeks to explore the use of emergent biosensor technology to detect
opioid use. The investigators goal is to recruit 60 opioid naïve patients presenting at the
College of Dentistry at UTHSC. Candidate participants must be scheduled for an upcoming
dental procedure that will involve subsequent pain management using oral opioid medication.
Participants will be consented prior to any study procedures. All participant information
from this study will be kept strictly confidential (e.g., no individual data will be shared
with the College of Dentistry).
Participants who are enrolled will complete baseline questionnaires regarding psychological
and behavioral risks of substance use. Next, participants will be asked to wear the wristband
sensor for 1 day prior to surgery, and up to 30 days post-surgery, or as long as opioid
medication is prescribed. Physiological measurement will be conducted via the Empatica E4
wristband biosensor, which measures electrodermal activity, skin temperature, and locomotion
data. Opioid use will detected through biosensor activity. Participants will be recruited
over a 6 month period, in cohorts of 10. All study procedures will be approved by the UTHSC
IRB.
Hilbert transform analyses combined with paired t-tests will be used to compare the biosensor
data: (A) within subjects, before and after administration of opioids; and (B) between
subjects, controlling for hand dominance, gender, and length of prescription.
Results of analyses will be shared with the College of Dentistry, and will subsequently be
disseminated through a peer-reviewed publication.
Role of the College of Dentistry:
- To refer patients to Karen Derefinko's study team for possible recruitment into the
study prior to the scheduled surgery.
- If possible, to allow a research coordinator to consent and interview participants on
site in an available private room.
- To provide prescription data (type, dose, and duration) to study team, with signed
participant consent.
Epigenetics:
Environmental exposures including prescription drugs and drugs of abuse can have a pronounce
effect on the epigenome (Nestler, 2014; Nielsen et al., 2012). There is growing evidence that
use of opioids results in changes in DNA methylation, an important epigenetic modification
that can alter gene expression. Such changes may play a mechanistic role in forming an
"epigenetic memory" of drug exposure and development of dependence (Doehring et al., 2013;
Tuesta & Zhang, 2014). For this study, the coordinator will collect buccal swabs (cheek
epithelial cells) from study subjects at the start of study and at follow up visits. Buccal
cells will be collected non-invasively using the DNA Genotek sample collection kits
(http://www.dnagenotek.com). The investigator will then perform genome-wide DNA methylation
assay using the Illumina Infinium MethylationEPIC array (https://www.illumina.com). The
investigator will evaluate the longitudinal change in the methylome that may be induced by
short-term opioid use.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
Completed |
NCT04110626 -
Realistic Evaluation of Expériences Animées, a School-based Intervention in Nouvelle Aquitaine
|
||
Completed |
NCT03007940 -
Using NIATx Strategies to Implement Integrated Services in Routine Care
|
N/A | |
Not yet recruiting |
NCT04030858 -
The INFINITE Study: A Prospective Investigation of a Nutrient-dense Diet in Early Addiction Recovery
|
N/A | |
Completed |
NCT03347643 -
The Effectiveness of tDCS on Internet Game Addiction
|
Phase 2 | |
Active, not recruiting |
NCT02836080 -
Integrated Collaborative Care Teams for Youth With Mental Health and/or Addiction Challenges (YouthCan IMPACT)
|
N/A | |
Completed |
NCT03221985 -
ESM Pilot: Mobile Phones and Psychology
|
N/A | |
Completed |
NCT02556060 -
Lamotrigine for Ketamine Dependence Trial
|
Phase 2/Phase 3 | |
Completed |
NCT01531153 -
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
|
N/A | |
Completed |
NCT02812810 -
Evaluation of the Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) Low-frequency on Craving in Smoking Dependence
|
N/A | |
Recruiting |
NCT05976646 -
Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion
|
Phase 1/Phase 2 | |
Completed |
NCT04409106 -
The Turkish Version of the Parental Smartphone Use Management Scale (PSUMS)
|
||
Not yet recruiting |
NCT06459609 -
Effect of Protein Supplementation on Craving in Subjects Hospitalised for Addiction Treatment
|
N/A | |
Recruiting |
NCT05595759 -
Violence Against Women in Patients With Alcohol Substance Addiction Training
|
N/A | |
Completed |
NCT04099173 -
A Brief Mindfulness-Based Intervention for Suicidal Ideation
|
N/A | |
Recruiting |
NCT04959643 -
Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospital
|
||
Completed |
NCT04133688 -
Mobile App in Addiction
|
N/A | |
Recruiting |
NCT04063267 -
Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder
|
Phase 2 | |
Completed |
NCT05114577 -
Recovery Sleepers: A Pilot Study of a Sleep Health Intervention for College Students in Recovery
|
N/A | |
Terminated |
NCT02671240 -
Prognosis of Behavioral Addiction in Parkinson's Disease
|